Date: September 9, 2026
Board Meeting Outcomes
RPG Active Pharma Limited (RPGAP), a wholly owned subsidiary of RPG Life Sciences Limited, has allotted securities to India Life Sciences Fund IV Domestic (ILSF) and Vistaject Fund (VJF) for a total consideration of INR 243.33 crores. This allotment constitutes 40% of the equity share capital of RPGAP.
The transaction was executed pursuant to an Investment and Shareholders' Agreement among RPG Life Sciences Limited, RPGAP, ILSF, and VJF that was previously executed on July 29, 2026.
Ownership & Subsidiary Status
Post this investment, RPGAP continues to remain a subsidiary of RPG Life Sciences Limited. The company maintains controlling ownership despite the 40% stake dilution to external investors.